Sinovac Biotech buy melinda
Start price
01.07.17
/
50%
€6.08
Target price
13.11.17
€7.22
Performance (%)
6.97%
End price
13.11.17
€6.50
Summary
This prediction ended on 13.11.17 with a price of €6.50. With a performance of 6.97%, the BUY prediction by melinda for Sinovac Biotech closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sinovac Biotech | - | - | - | - |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% | 47.267% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% | 68.687% |
Comments by melinda for this prediction
In the thread Sinovac Biotech diskutieren
Sinovac
Das Konsortium Shandong Sinobioway bietet Sinovac Biotech Privatisierung Angebot
28. Juni (Reuters) - Shandong Sinobioway Biomedicine Co Ltd: * sagt sein Konsortium Sinovac Biotech Ltd. bei $ 8 pro Aktie es privat zu ergreifen , um zu kaufen schlägt.
Das Konsortium Shandong Sinobioway bietet Sinovac Biotech Privatisierung Angebot
28. Juni (Reuters) - Shandong Sinobioway Biomedicine Co Ltd: * sagt sein Konsortium Sinovac Biotech Ltd. bei $ 8 pro Aktie es privat zu ergreifen , um zu kaufen schlägt.